What is the recommended site for bone marrow examination?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Site for Bone Marrow Examination

The posterior iliac crest is the preferred site for bone marrow examination due to its safety profile, specimen quality, and patient comfort. 1, 2, 3

Primary Recommended Site: Posterior Iliac Crest

  • The posterior iliac crest provides high-quality specimens with greater length and area compared to other sites 2
  • It is considered safer with fewer complications compared to sternal aspirations, which carry a rare risk of cardiac tamponade 4
  • Patients report significantly less pain with posterior iliac crest biopsies compared to anterior iliac crest procedures 2
  • The American College of Medical Genetics and Genomics (ACMG) specifically identifies bone marrow aspirate as the preferred specimen for most hematologic neoplasms, with the posterior iliac crest being the optimal site 1

Alternative Sites

  • Anterior iliac crest: Can be used but produces smaller specimens and causes more patient discomfort 2, 3
  • Sternum: Historically used but carries higher risk including rare fatal complications from cardiac tamponade 4
  • Bone marrow core biopsy: Required in cases with dry tap, requiring special processing techniques 1
  • Metaphysis of distal femur and proximal tibia: Alternative sites with similar cell phenotype and differentiation potential, but with lower mononuclear cell concentration compared to iliac crest 5

Procedural Considerations

  • Specimens should be collected under sterile conditions in sodium heparin tubes (not lithium heparin) 1
  • Optimal concentration of sodium heparin should be 20 IU/mL of specimen 1
  • For adults, approximately 1-3 mL of bone marrow should be collected 1
  • The first or second draw should be used for cytogenetic analysis as it typically contains more neoplastic bone marrow cells 1
  • Specimens should be transported at ambient temperature and received by the laboratory within 24 hours 1

Special Circumstances

  • For neuroblastoma detection, the International Neuroblastoma Risk Group Task Force recommends collecting the first bone marrow aspirate (2-5 ml) from each iliac crest 1
  • In lymphoma staging, PET-CT may replace the need for bone marrow biopsy in Hodgkin lymphoma if the PET scan is negative or shows homogeneous bone marrow uptake 1, 6
  • For patients with suspected plasma cell neoplasms, specific processing techniques may be required 1

Clinical Pearls and Pitfalls

  • When large sample volumes are required for multiple diagnostic tests, changing the bone marrow aspiration site is necessary to avoid hemodilution 1
  • If staying at the same puncture site, the needle should be reinserted at different angles 1
  • For biobanking purposes, all cells not used for diagnostics should be preserved, with viable cells stored in liquid nitrogen 1
  • In cases of dry tap, bone marrow core biopsy or smear/touch imprint preparations can be used for analysis 1
  • Specimens should be processed as soon as possible after receipt by the laboratory 1

The posterior iliac crest remains the gold standard site for bone marrow examination due to its optimal balance of safety, specimen quality, and patient comfort.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Bone marrow aspiration.

Journal of clinical pathology, 2001

Guideline

Diagnostic Role of Bone Marrow Examination in Pyrexia of Unknown Origin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.